Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07122219

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
548 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.

Detailed description

Using a step-wedge design, we will conduct a Type 2 hybrid implementation trial to assess the extent to which PNEP uptake is improved over 24 months of observation using the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy bundle. Nine prisons were non-randomly\* allocated to one of three groups, with the groups receiving the intervention (i.e., NIATx) over 24 months at staggered time intervals (every 6 months). This will be followed by an additional 12 month post-intervention period, when sustainability will be assessed. \*Originally randomized; allocation was modified due to logistical constraints

Conditions

Interventions

TypeNameDescription
BEHAVIORALNIATxThe Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.

Timeline

Start date
2024-10-01
Primary completion
2028-02-29
Completion
2029-09-30
First posted
2025-08-14
Last updated
2025-12-29

Locations

9 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT07122219. Inclusion in this directory is not an endorsement.